X Health (USA) and REVIV Global (UK) today announced a strategic partnership with M42, a global health leader powered by technology, artificial intelligence and genomics, headquartered in Abu Dhabi, ...

To raise awareness about the health impact of diabetes-related misconceptions, Abbott launched the Above the Bias initiative.

We who have smartphones or tablets and have time to spare or waste often start reading articles which mysteriously pop up, ...

Diabetes is a serious and usually life-long condition that causes blood sugar levels to become too high - and there are a ...

Trends, Growth Drivers, Challenges, Opportunities, and Competitive Landscape: The artificial sweetener market is experiencing ...

What a prediabetic diagnosis means and the food you should avoid - A prediabetic diagnosis can serve as a health warning and ...

The NHS has issued a cautionary note on its website for those taking metformin, particularly those who have been on the medication for an extended period. Metformin is a commonly prescribed drug for ...

Eli Lilly has guided its oral GLP-1 drug candidate orforglipron through two more late-phase tests in Type 2 diabetes, racking up wins against placebo and AstraZeneca’s Farxiga to stay on track to seek ...

A number of doctors are warning of a skin condition that could signal your diet may be too high in sugar, which can lead to type 2 diabetes. According to the 2024 National Diabetes Statistics Report, ...

Artificial intelligence (AI) is steadily reshaping diabetes care, from diagnostic advances to providing new tools that lighten patients’ daily management burden, according to experts in the field.

Restoring a normal fasting blood sugar level prevents the development of type 2 diabetes just as well as reducing “the number on the scale,” latest research has revealed. A new study from the ...